Abstract
The tumor microenvironment (TME) plays an essential role in the occurrence and progression of malignancy. The potential prognostic TME-related biomarkers of lung adenocarcinoma (LUAD) remained unclear, which were investigated in this research. The RNA-sequencing profiles and corresponding clinical parameters were extracted from TCGA and GEO databases, based on which the stromal and immune scores were calculated through the ESTIMATE algorithm. Overlapping differentially expressed genes between stromal and immune score group were analyzed by the LASSO and Random Forrest algorithms and validated in cases from our center. And a prognostic 8-gene signature was constructed using Cox regression. The infiltration of 22 hematopoietic cell phenotypes was assessed by the CIBERSORT algorithms. We found that female, elder patients, and solid predominant subtype had obviously higher stromal and immune scores. And patients with early stage LUAD received a prominently higher immune score. A high stromal or immune score meant a good prognosis. Subsequently, eight TME-related prognostic genes (ATAD5, CYP4F3, CYP4F12, ESPNL, FXYD2, GPX2, NLGN4Y, and SERPINC1) were identified by both LASSO regression and Radom Forest algorithms. High 8-gene signature group exhibited worse overall survival. Furthermore, B cell naïve, plasma cells, T cell follicular helper, and macrophages M1 were prominently more in high signature group. Nevertheless, fewer T cells CD4 memory resting, monocytes, and dendritic cell resting were identified in the high signature group. The composition of the tumor microenvironment significantly affected the prognosis of LUAD patients. We provided a new strategy for the exploration of prognostic TME-related biomarkers and immunotherapy.
Similar content being viewed by others
Data availability
The RNA-sequencing profiles and corresponding clinical phenotypes were extracted from TCGA and GEO database, which were open-access.
Code availability
R software (version 3.63) was used for analysis and plotting.
References
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539–545
Brigelius-Flohé R, Kipp AP (2012) Physiological functions of GPx2 and its role in inflammation-triggered carcinogenesis. Ann N Y Acad Sci 1259:19–25
Chen CH, Lu YS, Cheng AL, Huang CS, Kuo WH, Wang MY, Chao M, Chen IC, Kuo CW, Lu TP, Lin CH (2020) Disparity in tumor immune microenvironment of breast cancer and prognostic impact: Asian versus Western populations. ONCOLOGIST 25:e16–e23
Chen P, Yang Y, Zhang Y, Jiang S, Li X, Wan J (2020) Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer. Aging (Albany NY) 12:3371–3387
Cuocolo R, Caruso M, Perillo T, Ugga L, Petretta M (2020) Machine learning in oncology: a clinical appraisal. Cancer Lett 481:55–62
Fehlmann T, Kahraman M, Ludwig N, Backes C, Galata V, Keller V, Geffers L, Mercaldo N, Hornung D, Weis T, Kayvanpour E, Abu-Halima M, Deuschle C, Schulte C, Suenkel U, von Thaler AK, Maetzler W, Herr C, Fahndrich S, Vogelmeier C, Guimaraes P, Hecksteden A, Meyer T, Metzger F, Diener C, Deutscher S, Abdul-Khaliq H, Stehle I, Haeusler S, Meiser A, Groesdonk HV, Volk T, Lenhof HP, Katus H, Balling R, Meder B, Kruger R, Huwer H, Bals R, Meese E, Keller A (2020) Evaluating the use of circulating MicroRNA profiles for lung cancer detection in symptomatic patients. JAMA Oncol 6:714–723
Gandhi AV, Saxena S, Relles D, Sarosiek K, Kang CY, Chipitsyna G, Sendecki JA, Yeo CJ, Arafat HA (2013) Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma. Ann Surg Oncol 20 Suppl 3:S636–S643
Gaut JP, Crimmins DL, Lockwood CM, McQuillan JJ, Ladenson JH (2013) Expression of the Na+/K+-transporting ATPase gamma subunit FXYD2 in renal tumors. Mod Pathol 26:716–724
Gazy I, Liefshitz B, Parnas O, Kupiec M (2015) Elg1, a central player in genome stability. Mutat Res Rev Mutat Res 763:267–279
Geering K (2006) FXYD proteins: new regulators of Na-K-ATPase. Am J Physiol Renal Physiol 290:F241–F250
Giraldo NA, Sanchez-Salas R, Peske JD, Vano Y, Becht E, Petitprez F, Validire P, Ingels A, Cathelineau X, Fridman WH, Sautès-Fridman C (2019) The clinical role of the TME in solid cancer. Br J Cancer 120:45–53
Gong Y, Wang L, Chippada-Venkata U, Dai X, Oh WK, Zhu J (2016) Constructing Bayesian networks by integrating gene expression and copy number data identifies NLGN4Y as a novel regulator of prostate cancer progression. Oncotarget 7:68688–68707
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hardwick JP (2008) Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases. Biochem Pharmacol 75:2263–2275
Jiang Y, Zhang Q, Hu Y, Li T, Yu J, Zhao L, Ye G, Deng H, Mou T, Cai S, Zhou Z, Liu H, Chen G, Li G, Qi X (2018) ImmunoScore signature: a prognostic and predictive tool in gastric cancer. Ann Surg 267:504–513
Lanczky A, Nagy A, Bottai G, Munkacsy G, Szabo A, Santarpia L, Gyorffy B (2016) miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat 160:439–446
Liu K, Jin M, Xiao L, Liu H, Wei S (2018) Distinct prognostic values of mRNA expression of glutathione peroxidases in non-small cell lung cancer. Cancer Manag Res 10:2997–3005
Liu S, Li S, Wang Y, Wang F, Zhang L, Xian S, Yang D, Yuan M, Dai F, Zhao X, Liu Y, Jin Y, Zeng Z, Mahgoub O, Zhou C, Cheng Y (2020) Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC). J Cell Biochem 121:2571–2581
Lu Z, Wang F, Liang M (2017) SerpinC1/Antithrombin III in kidney-related diseases. Clin Sci (Lond) 131:823–831
Saito M, Shiraishi K, Kunitoh H, Takenoshita S, Yokota J, Kohno T (2016) Gene aberrations for precision medicine against lung adenocarcinoma. Cancer Sci 107:713–720
Mizuno H, Kitada K, Nakai K, Sarai A (2009) PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2:18
Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453–457
Olingy CE, Dinh HQ, Hedrick CC (2019) Monocyte heterogeneity and functions in cancer. J Leukoc Biol 106:309–322
Peltier J, Roperch JP, Audebert S, Borg JP, Camoin L (2016) Quantitative proteomic analysis exploring progression of colorectal cancer: modulation of the serpin family. J Proteomics 148:139–148
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437
Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Varambally R, Yu J, Briggs BB, Barrette TR, Anstet MJ, Kincead-Beal C, Kulkarni P, Varambally S, Ghosh D, Chinnaiyan AM (2007) Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia 9:166–180
Saito M, Shiraishi K, Kunitoh H, Takenoshita S, Yokota J, Kohno T (2016) Gene aberrations for precision medicine against lung adenocarcinoma. Cancer Sci 107:713–720
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504
Sharma P, Hu-Lieskovan S, Wargo JA, Ribas A (2017) Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell 168:707–723
Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607–D613
Tibshirani R (1997) The lasso method for variable selection in the Cox model. Stat Med 16:385–395
Welsh TJ, Green RH, Richardson D, Waller DA, O’Byrne KJ, Bradding P (2005) Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23:8959–8967
Yan H, Qu J, Cao W, Liu Y, Zheng G, Zhang E, Cai Z (2019) Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. Cancer Immunol Immunother 68:1971–1978
Yang HI, Yuen MF, Chan HL, Han KH, Chen PJ, Kim DY, Ahn SH, Chen CJ, Wong VW, Seto WK (2011) Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score. Lancet Oncol 12:568–574
Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W, Trevino V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RG (2013) Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 4:2612
Zeng D, Zhou R, Yu Y, Luo Y, Zhang J, Sun H, Bin J, Liao Y, Rao J, Zhang Y, Liao W (2018) Gene expression profiles for a prognostic immunoscore in gastric cancer. Br J Surg 105:1338–1348
Funding
This work was supported by the National Natural Science Foundation of China (Grant Nos. 81672268).
Author information
Authors and Affiliations
Contributions
Mengnan Zhao: study design, analysis, and interpretation of data, drafting the article, final approval; Zhencong Chen: study design, analysis, and interpretation of data, drafting the article, final approval; Ming Li: study design, analysis, and interpretation of data, drafting the article, final approval; Yunyi Bian: acquisition of data, drafting the article, revising the article, final approval; Yuansheng Zheng: analysis and interpretation of data, drafting the article, final approval; Zhengyang Hu: analysis and interpretation of data, drafting the article, final approval; Jiaqi Liang: analysis and interpretation of data, drafting the article, final approval; Yiwei Huang: analysis and interpretation of data, drafting the article, final approval; Jiacheng Yin: analysis and interpretation of data, drafting the article, final approval; Cheng Zhan: study design, analysis and interpretation of data, drafting the article, revising the article critically for important intellectual content, final approval, agreement to be accountable for all aspects of the work; Mingxiang Feng: study design, drafting the article, revising the article critically for important intellectual content, final approval, agreement to be accountable for all aspects of the work; Qun Wang: study design, drafting the article, revising the article critically for important intellectual content, final approval.
Corresponding authors
Ethics declarations
Conflict of interests
The authors declare that they have no conflict of interest.
Ethics approval
This study was conducted with approval by the Ethics Committee of Zhongshan Hospital, Fudan University, Shanghai, China (Approval No. B2017-042).
Consent to participate
Written informed consent was obtained from all patients.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Zhao, M., Li, M., Chen, Z. et al. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma. Immunogenetics 72, 455–465 (2020). https://doi.org/10.1007/s00251-020-01189-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-020-01189-z